Your browser is no longer supported. Please, upgrade your browser.
Settings
COCP Cocrystal Pharma, Inc. daily Stock Chart
COCP [NASD]
Cocrystal Pharma, Inc.
Index- P/E- EPS (ttm)-1.49 Insider Own64.15% Shs Outstand28.07M Perf Week-26.11%
Market Cap42.11M Forward P/E- EPS next Y-0.40 Insider Trans- Shs Float11.26M Perf Month-18.92%
Income-44.70M PEG- EPS next Q-0.08 Inst Own13.00% Short Float0.86% Perf Quarter-28.57%
Sales5.70M P/S7.39 EPS this Y- Inst Trans0.03% Short Ratio13.79 Perf Half Y-44.03%
Book/sh2.29 P/B0.66 EPS next Y- ROA-52.00% Target Price11.00 Perf Year-44.44%
Cash/sh0.27 P/C5.61 EPS next 5Y- ROE-55.20% 52W Range1.31 - 5.28 Perf YTD-58.33%
Dividend- P/FCF- EPS past 5Y3.00% ROI- 52W High-71.59% Beta0.86
Dividend %- Quick Ratio4.60 Sales past 5Y- Gross Margin- 52W Low14.50% ATR0.17
Employees10 Current Ratio4.60 Sales Q/Q- Oper. Margin- RSI (14)34.86 Volatility14.16% 8.82%
OptionableNo Debt/Eq0.00 EPS Q/Q1.10% Profit Margin- Rel Volume0.93 Prev Close1.33
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume6.98K Price1.50
Recom- SMA20-22.38% SMA50-29.11% SMA200-40.88% Volume6,450 Change12.78%
Oct-08-19 09:15AM  Cocrystal Pharma Presents Data at the 26th International Symposium on Hepatitis C Virus and Related Viruses GlobeNewswire -8.63%
Oct-01-19 08:00AM  Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus and Related Viruses GlobeNewswire
Sep-26-19 08:05AM  Cocrystal Pharma to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire -6.05%
Sep-10-19 01:11PM  Those Who Purchased Cocrystal Pharma (NASDAQ:COCP) Shares Three Years Ago Have A 87% Loss To Show For It Simply Wall St.
Sep-03-19 08:05AM  Cocrystal Pharma Presents Positive Preclinical Data for CC-42344 at the Options X for the Control of Influenza Conference GlobeNewswire
Aug-21-19 08:05AM  Cocrystal Pharma Announces Abstract Accepted for Oral Presentation at the ISIRV: Options X for the Control of Influenza Conference GlobeNewswire
Aug-09-19 08:05AM  Cocrystal Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire -12.15%
Jul-26-19 08:10AM  Cocrystal Pharma, Inc. (NASDAQ:COCP): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
Jun-19-19 06:03AM  Do Insiders Own Shares In Cocrystal Pharma, Inc. (NASDAQ:COCP)? Simply Wall St.
May-20-19 08:05AM  Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus GlobeNewswire
May-10-19 08:35AM  Cocrystal Pharma Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Apr-01-19 08:35AM  Cocrystal Pharma Reports 2018 Financial Results and Provides Corporate Overview and Business Outlook GlobeNewswire
Mar-11-19 08:30AM  Cocrystal Pharma Announces Closing of Private Placement GlobeNewswire
Jan-22-19 04:00PM  Penny Stocks to Buy Using Technical Analysis for January 2019 Investopedia -15.80%
08:00AM  Cocrystal Pharma Provides Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus GlobeNewswire
Jan-18-19 04:18PM  Robbins Arroyo LLP: Shareholder Lawsuit Says Cocrystal Pharma, Inc. (COCP) Misled Shareholders Business Wire
Jan-07-19 08:30AM  Cocrystal Announces Board Changes GlobeNewswire -8.78%
Jan-03-19 10:35AM  4 Pharma Stocks Raising Eyebrows (1/3/19) ACCESSWIRE +9.52%
08:48AM  UPDATE: Cocrystal Pharma to work with Merck on flu therapy, sending shares up 32% premarket MarketWatch
08:30AM  Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck GlobeNewswire
Nov-30-18 08:00AM  Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference GlobeNewswire
Nov-29-18 11:05AM  WeissLaw LLP: Cocrystal Pharma, Inc. is the Subject of a Legal Investigation ACCESSWIRE
Nov-19-18 11:40AM  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses of $100,000 to Contact the Firm Business Wire
09:25AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline November 19, 2018 ACCESSWIRE
08:40AM  Detailed Research: Economic Perspectives on Cocrystal Pharma, Genius Brands International, Gemphire Therapeutics, Global Water Resources, Infrastructure and Energy Alternatives, and Condor Hospitality Trust What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-18-18 09:00AM  CLASS ACTION UPDATE for COCP, JT and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Nov-16-18 07:30PM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
10:37AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DY GlobeNewswire
09:00AM  COCP DEADLINE NOTICE ALERT: Rosen Law Firm Reminds Cocrystal Pharma, Inc. Investors of Important Nov. 19 Deadline in First Filed Case COCP GlobeNewswire
Nov-15-18 04:28PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Cocrystal Pharma, Inc. To Contact The Firm GlobeNewswire
01:37PM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:51AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline - November 19, 2018 ACCESSWIRE
Nov-14-18 09:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE
05:00PM  FINAL DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
04:04PM  SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
03:00PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. COCP ACCESSWIRE
09:15AM  Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges Zacks
Nov-13-18 05:19PM  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cocrystal Pharma, Inc. GlobeNewswire +31.71%
03:09PM  CLASS ACTION UPDATE for MCHP, COCP and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:55PM  6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
11:50AM  Cocrystal Pharma Announces Presentation of Preclinical Characterization Data of CC-42344 at the 6th ISIRV-AVG Conference GlobeNewswire
10:51AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of USAT, COCP, TRVN, HTHT and SFIX GlobeNewswire
10:06AM  Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Cocrystal Pharma, Inc., formerly known as BioZone Pharmaceuticals, Inc. (COCP) and November 19 Lead Plaintiff Deadline Business Wire
09:50AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline November 19, 2018 ACCESSWIRE
Nov-12-18 07:39PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tribune, USA Technologies, and Cocrystal and Encourages Investors to Contact the Firm GlobeNewswire +12.02%
07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE
05:25PM  NOVEMBER 19 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:19PM  SHAREHOLDER ALERT: APOG COCP ABBV COST HTHT SFIX CWH OZK NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
08:00AM  Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update GlobeNewswire
Nov-11-18 12:00PM  CLASS ACTION UPDATE for MCHP, COCP and HTHT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Nov-10-18 08:28AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Nov-09-18 07:16PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP GlobeNewswire
Nov-08-18 05:55PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, SFIX, CWH, HON, NKTR and SYF GlobeNewswire +17.79%
02:00PM  DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:11PM  SHAREHOLDER ALERT: MCHP COCP ABBV JT TRVN SFIX CWH HON ALGN NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Nov-07-18 06:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE
04:20PM  SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:45PM  CLASS ACTION UPDATE for COCP and NKTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:34AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline - November 19, 2018 ACCESSWIRE
Nov-06-18 05:31PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Cocrystal Pharma, Inc. To Contact The Firm Business Wire +6.25%
04:11PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, TGTX, HAS, ADNT and GOOG GlobeNewswire
Nov-05-18 07:02PM  INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire -10.11%
05:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE
02:48PM  SHAREHOLDER ALERT: PVG USAT COCP JT GOOG OZK NKTR FIT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
01:48PM  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cocrystal Pharma, Inc. Business Wire
01:45PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. - COCP ACCESSWIRE
Nov-04-18 11:00AM  CLASS ACTION UPDATE for USAT, COCP and HAS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Nov-02-18 09:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP GlobeNewswire
02:42PM  SHAREHOLDER ALERT: OPK PM QRTEA TRCO PVG COCP ABBV ALNY MGTI CHGG CWH DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
11:33AM  COCP LOSS ALERT: Rosen Law Firm Reminds Cocrystal Pharma, Inc. Investors of Important Deadline in First Filed Case; Important Deadline - COCP PR Newswire
Nov-01-18 09:46PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qurate, OPKO Health and Cocrystal and Encourages Investors to Contact the Firm GlobeNewswire
03:42PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, PVG, COCP, ABBV and ADNT GlobeNewswire
Oct-31-18 09:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE +12.12%
12:30PM  CLASS ACTION UPDATE for COCP, HTHT and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline November 19, 2018 GlobeNewswire
Oct-30-18 05:15PM  SHAREHOLDER ALERT: COCP TGTX ABBV ALNY MGTI HAS CPB HTHT SFIX GOOG OZK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
04:21PM  Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cocrystal Pharma, Inc. Business Wire
03:51PM  Lifshitz & Miller LLP Announces Investigation of Adient PLC, Applied Optoelectronics, Inc., Cocrystal Pharma, Inc., Microchip Technology Incorporated, MGT Capital Investments, Inc., TG Therapeutics, Inc. and USA Technologies, Inc. PR Newswire
01:55PM  SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:13PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of QRTEA, TRCO, USAT, COCP and CHGG GlobeNewswire
12:06PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Cocrystal Pharma, Inc. (Nasdaq: COCP), f/k/a/ BioZone Pharmaceuticals, Inc., To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
Oct-29-18 07:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE -8.60%
Oct-28-18 11:30AM  CLASS ACTION UPDATE for TRCO, COCP and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Oct-26-18 05:23PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP GlobeNewswire -6.06%
03:55PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. - COCP ACCESSWIRE
02:05PM  SHAREHOLDER ALERT: LCI CBS QRTEA USAT COCP ALNY CHGG JT DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline November 19, 2018 GlobeNewswire
Oct-25-18 04:32PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRCO, COCP, ALNY and CHGG GlobeNewswire
Oct-24-18 06:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE -21.92%
04:36PM  COCP ALERT: Rosen Law Firm Reminds Cocrystal Pharma, Inc. Investors of Important Deadline in First Filed Case COCP GlobeNewswire
04:10PM  Cocrystal Pharma, Inc. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Cocrystal Pharma, Inc. (f/k/a/ BioZone Pharmaceuticals, Inc.) GlobeNewswire
04:00PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. - COCP ACCESSWIRE
Oct-23-18 03:55PM  SHAREHOLDER ALERT: AMPE LCI PZZA SKX PM USAT COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
11:17AM  Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Cocrystal Pharma, Inc., formerly known as BioZone Pharmaceuticals, Inc. (COCP) and November 19 Plaintiff Deadline Business Wire
10:42AM  CLASS ACTION UPDATE for COCP, TGTX and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Oct-22-18 09:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tribune Media, Microchip Technology, and Cocrystal and Encourages Investors to Contact the Firm GlobeNewswire
08:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP ACCESSWIRE
02:19PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBS, COCP, TGTX and TRVN GlobeNewswire
01:25PM  INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-21-18 11:00AM  SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Cocrystal Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of various antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that is in Phase 2a clinical trial to treat HCV; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza. It is also involved in identifying and developing various non-nucleoside polymerase inhibitors for norovirus gastroenteritis. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck & Co., Inc. to discover and develop proprietary influenza A/B antiviral agents; and a collaboration agreement National Institute of Health. The company was founded in 2007 and is headquartered in Tucker, Georgia.